Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

This study has been terminated.
(Enrollment issues)
Sponsor:
Collaborator:
University of Wisconsin, Madison
Information provided by (Responsible Party):
ProCertus BioPharm, Inc
ClinicalTrials.gov Identifier:
NCT01263366
First received: December 16, 2010
Last updated: April 17, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)